nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—ALB—atherosclerosis	0.252	1	CbGaD
Sulfamethoxazole—ALB—Rosuvastatin—atherosclerosis	0.0709	0.151	CbGbCtD
Sulfamethoxazole—CYP2C8—Simvastatin—atherosclerosis	0.0509	0.108	CbGbCtD
Sulfamethoxazole—CYP2C8—Pravastatin—atherosclerosis	0.0499	0.106	CbGbCtD
Sulfamethoxazole—CYP2C8—Lovastatin—atherosclerosis	0.0499	0.106	CbGbCtD
Sulfamethoxazole—CYP2C9—Rosuvastatin—atherosclerosis	0.0382	0.0812	CbGbCtD
Sulfamethoxazole—CYP2C9—Simvastatin—atherosclerosis	0.0355	0.0755	CbGbCtD
Sulfamethoxazole—CYP2C9—Lovastatin—atherosclerosis	0.0348	0.0739	CbGbCtD
Sulfamethoxazole—CYP2C9—Pravastatin—atherosclerosis	0.0348	0.0739	CbGbCtD
Sulfamethoxazole—CYP3A4—Ezetimibe—atherosclerosis	0.0222	0.0472	CbGbCtD
Sulfamethoxazole—CYP3A4—Rosuvastatin—atherosclerosis	0.0222	0.0472	CbGbCtD
Sulfamethoxazole—CYP3A4—Simvastatin—atherosclerosis	0.0207	0.0439	CbGbCtD
Sulfamethoxazole—CYP3A4—Lovastatin—atherosclerosis	0.0202	0.043	CbGbCtD
Sulfamethoxazole—CYP3A4—Pravastatin—atherosclerosis	0.0202	0.043	CbGbCtD
Sulfamethoxazole—Sulfisoxazole—EDNRA—atherosclerosis	0.00199	0.539	CrCbGaD
Sulfamethoxazole—Rhabdomyolysis—Lovastatin—atherosclerosis	0.00156	0.0101	CcSEcCtD
Sulfamethoxazole—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.00153	0.00991	CcSEcCtD
Sulfamethoxazole—Jaundice cholestatic—Simvastatin—atherosclerosis	0.00147	0.00951	CcSEcCtD
Sulfamethoxazole—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00146	0.00945	CcSEcCtD
Sulfamethoxazole—Jaundice cholestatic—Niacin—atherosclerosis	0.00135	0.00874	CcSEcCtD
Sulfamethoxazole—Rhabdomyolysis—Niacin—atherosclerosis	0.00134	0.00867	CcSEcCtD
Sulfamethoxazole—Jaundice cholestatic—Pravastatin—atherosclerosis	0.00133	0.0086	CcSEcCtD
Sulfamethoxazole—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00132	0.00854	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Lovastatin—atherosclerosis	0.00114	0.00739	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Lovastatin—atherosclerosis	0.00112	0.00725	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Ezetimibe—atherosclerosis	0.00112	0.00725	CcSEcCtD
Sulfamethoxazole—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00111	0.00719	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Simvastatin—atherosclerosis	0.00107	0.00691	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Simvastatin—atherosclerosis	0.00105	0.00678	CcSEcCtD
Sulfamethoxazole—Purpura—Lovastatin—atherosclerosis	0.00104	0.00673	CcSEcCtD
Sulfamethoxazole—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00104	0.00672	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Rosuvastatin—atherosclerosis	0.001	0.00649	CcSEcCtD
Sulfamethoxazole—Polyuria—Niacin—atherosclerosis	0.000978	0.00635	CcSEcCtD
Sulfamethoxazole—Purpura—Simvastatin—atherosclerosis	0.000971	0.0063	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Pravastatin—atherosclerosis	0.000963	0.00625	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Pravastatin—atherosclerosis	0.000946	0.00613	CcSEcCtD
Sulfamethoxazole—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000937	0.00608	CcSEcCtD
Sulfamethoxazole—Depression—Rosuvastatin—atherosclerosis	0.000907	0.00588	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.000901	0.00584	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000892	0.00578	CcSEcCtD
Sulfamethoxazole—Purpura—Pravastatin—atherosclerosis	0.000878	0.00569	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00086	0.00558	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Lovastatin—atherosclerosis	0.000856	0.00555	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Lovastatin—atherosclerosis	0.000848	0.0055	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000843	0.00546	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Ezetimibe—atherosclerosis	0.00084	0.00544	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Ezetimibe—atherosclerosis	0.000831	0.00539	CcSEcCtD
Sulfamethoxazole—Hepatitis—Rosuvastatin—atherosclerosis	0.000817	0.0053	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Simvastatin—atherosclerosis	0.000801	0.00519	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Simvastatin—atherosclerosis	0.000793	0.00514	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000789	0.00512	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000774	0.00502	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000764	0.00496	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000762	0.00494	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Ezetimibe—atherosclerosis	0.000756	0.0049	CcSEcCtD
Sulfamethoxazole—Infestation—Ezetimibe—atherosclerosis	0.000756	0.0049	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000756	0.0049	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000741	0.00481	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000738	0.00479	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Pravastatin—atherosclerosis	0.000724	0.00469	CcSEcCtD
Sulfamethoxazole—Depression—Simvastatin—atherosclerosis	0.000719	0.00466	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Pravastatin—atherosclerosis	0.000717	0.00465	CcSEcCtD
Sulfamethoxazole—Mental disorder—Rosuvastatin—atherosclerosis	0.000715	0.00464	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000715	0.00464	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000715	0.00464	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000707	0.00458	CcSEcCtD
Sulfamethoxazole—Hepatitis—Lovastatin—atherosclerosis	0.000692	0.00449	CcSEcCtD
Sulfamethoxazole—Hepatitis—Ezetimibe—atherosclerosis	0.000679	0.0044	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000667	0.00433	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000667	0.00433	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Lovastatin—atherosclerosis	0.000654	0.00424	CcSEcCtD
Sulfamethoxazole—Depression—Pravastatin—atherosclerosis	0.00065	0.00422	CcSEcCtD
Sulfamethoxazole—Angioedema—Rosuvastatin—atherosclerosis	0.000649	0.00421	CcSEcCtD
Sulfamethoxazole—Hepatitis—Simvastatin—atherosclerosis	0.000647	0.0042	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000646	0.00419	CcSEcCtD
Sulfamethoxazole—Stomatitis—Niacin—atherosclerosis	0.000645	0.00419	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Ezetimibe—atherosclerosis	0.000642	0.00416	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000639	0.00414	CcSEcCtD
Sulfamethoxazole—Chills—Lovastatin—atherosclerosis	0.000621	0.00403	CcSEcCtD
Sulfamethoxazole—Cough—Rosuvastatin—atherosclerosis	0.00062	0.00402	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Ezetimibe—atherosclerosis	0.000613	0.00398	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Simvastatin—atherosclerosis	0.000612	0.00397	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000612	0.00397	CcSEcCtD
Sulfamethoxazole—Arthralgia—Rosuvastatin—atherosclerosis	0.000605	0.00392	CcSEcCtD
Sulfamethoxazole—Myalgia—Rosuvastatin—atherosclerosis	0.000605	0.00392	CcSEcCtD
Sulfamethoxazole—Mental disorder—Ezetimibe—atherosclerosis	0.000595	0.00386	CcSEcCtD
Sulfamethoxazole—Hepatitis—Niacin—atherosclerosis	0.000594	0.00385	CcSEcCtD
Sulfamethoxazole—Malnutrition—Ezetimibe—atherosclerosis	0.000591	0.00383	CcSEcCtD
Sulfamethoxazole—Hepatitis—Pravastatin—atherosclerosis	0.000585	0.0038	CcSEcCtD
Sulfamethoxazole—Chills—Simvastatin—atherosclerosis	0.000581	0.00377	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000569	0.00369	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000568	0.00368	CcSEcCtD
Sulfamethoxazole—Mental disorder—Simvastatin—atherosclerosis	0.000567	0.00368	CcSEcCtD
Sulfamethoxazole—Eye disorder—Niacin—atherosclerosis	0.000555	0.0036	CcSEcCtD
Sulfamethoxazole—Tinnitus—Niacin—atherosclerosis	0.000554	0.00359	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Pravastatin—atherosclerosis	0.000553	0.00359	CcSEcCtD
Sulfamethoxazole—Angioedema—Lovastatin—atherosclerosis	0.00055	0.00357	CcSEcCtD
Sulfamethoxazole—Tinnitus—Pravastatin—atherosclerosis	0.000546	0.00354	CcSEcCtD
Sulfamethoxazole—Vertigo—Lovastatin—atherosclerosis	0.000541	0.00351	CcSEcCtD
Sulfamethoxazole—Angioedema—Ezetimibe—atherosclerosis	0.00054	0.0035	CcSEcCtD
Sulfamethoxazole—Leukopenia—Lovastatin—atherosclerosis	0.000539	0.0035	CcSEcCtD
Sulfamethoxazole—Chills—Niacin—atherosclerosis	0.000533	0.00346	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000529	0.00343	CcSEcCtD
Sulfamethoxazole—Chills—Pravastatin—atherosclerosis	0.000525	0.00341	CcSEcCtD
Sulfamethoxazole—Insomnia—Rosuvastatin—atherosclerosis	0.000525	0.0034	CcSEcCtD
Sulfamethoxazole—Malnutrition—Niacin—atherosclerosis	0.000517	0.00336	CcSEcCtD
Sulfamethoxazole—Cough—Ezetimibe—atherosclerosis	0.000516	0.00334	CcSEcCtD
Sulfamethoxazole—Angioedema—Simvastatin—atherosclerosis	0.000515	0.00334	CcSEcCtD
Sulfamethoxazole—Myalgia—Lovastatin—atherosclerosis	0.000513	0.00333	CcSEcCtD
Sulfamethoxazole—Arthralgia—Lovastatin—atherosclerosis	0.000513	0.00333	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Rosuvastatin—atherosclerosis	0.000511	0.00331	CcSEcCtD
Sulfamethoxazole—Tension—Niacin—atherosclerosis	0.000508	0.00329	CcSEcCtD
Sulfamethoxazole—Vertigo—Simvastatin—atherosclerosis	0.000506	0.00328	CcSEcCtD
Sulfamethoxazole—Leukopenia—Simvastatin—atherosclerosis	0.000504	0.00327	CcSEcCtD
Sulfamethoxazole—Arthralgia—Ezetimibe—atherosclerosis	0.000503	0.00326	CcSEcCtD
Sulfamethoxazole—Myalgia—Ezetimibe—atherosclerosis	0.000503	0.00326	CcSEcCtD
Sulfamethoxazole—Nervousness—Niacin—atherosclerosis	0.000502	0.00326	CcSEcCtD
Sulfamethoxazole—Tension—Pravastatin—atherosclerosis	0.0005	0.00324	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0005	0.00324	CcSEcCtD
Sulfamethoxazole—Nervousness—Pravastatin—atherosclerosis	0.000495	0.00321	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Lovastatin—atherosclerosis	0.000492	0.00319	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000482	0.00313	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Lovastatin—atherosclerosis	0.000481	0.00312	CcSEcCtD
Sulfamethoxazole—Arthralgia—Simvastatin—atherosclerosis	0.00048	0.00311	CcSEcCtD
Sulfamethoxazole—Myalgia—Simvastatin—atherosclerosis	0.00048	0.00311	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000474	0.00308	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Ezetimibe—atherosclerosis	0.000473	0.00307	CcSEcCtD
Sulfamethoxazole—Angioedema—Niacin—atherosclerosis	0.000473	0.00307	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000472	0.00306	CcSEcCtD
Sulfamethoxazole—Anorexia—Lovastatin—atherosclerosis	0.000469	0.00304	CcSEcCtD
Sulfamethoxazole—Skin disorder—Ezetimibe—atherosclerosis	0.000468	0.00304	CcSEcCtD
Sulfamethoxazole—Angioedema—Pravastatin—atherosclerosis	0.000465	0.00302	CcSEcCtD
Sulfamethoxazole—Vertigo—Niacin—atherosclerosis	0.000465	0.00301	CcSEcCtD
Sulfamethoxazole—Leukopenia—Niacin—atherosclerosis	0.000463	0.003	CcSEcCtD
Sulfamethoxazole—Urticaria—Rosuvastatin—atherosclerosis	0.000461	0.00299	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Simvastatin—atherosclerosis	0.00046	0.00298	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Rosuvastatin—atherosclerosis	0.000459	0.00297	CcSEcCtD
Sulfamethoxazole—Vertigo—Pravastatin—atherosclerosis	0.000458	0.00297	CcSEcCtD
Sulfamethoxazole—Leukopenia—Pravastatin—atherosclerosis	0.000456	0.00296	CcSEcCtD
Sulfamethoxazole—Cough—Niacin—atherosclerosis	0.000451	0.00293	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Simvastatin—atherosclerosis	0.00045	0.00292	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000448	0.0029	CcSEcCtD
Sulfamethoxazole—Insomnia—Lovastatin—atherosclerosis	0.000445	0.00288	CcSEcCtD
Sulfamethoxazole—Cough—Pravastatin—atherosclerosis	0.000445	0.00288	CcSEcCtD
Sulfamethoxazole—Myalgia—Niacin—atherosclerosis	0.00044	0.00286	CcSEcCtD
Sulfamethoxazole—Arthralgia—Niacin—atherosclerosis	0.00044	0.00286	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000439	0.00285	CcSEcCtD
Sulfamethoxazole—Anorexia—Simvastatin—atherosclerosis	0.000438	0.00284	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Lovastatin—atherosclerosis	0.000438	0.00284	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000437	0.00284	CcSEcCtD
Sulfamethoxazole—Insomnia—Ezetimibe—atherosclerosis	0.000436	0.00283	CcSEcCtD
Sulfamethoxazole—Arthralgia—Pravastatin—atherosclerosis	0.000434	0.00281	CcSEcCtD
Sulfamethoxazole—Myalgia—Pravastatin—atherosclerosis	0.000434	0.00281	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Lovastatin—atherosclerosis	0.000433	0.00281	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Ezetimibe—atherosclerosis	0.00043	0.00279	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000427	0.00277	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Lovastatin—atherosclerosis	0.000427	0.00277	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Ezetimibe—atherosclerosis	0.000424	0.00275	CcSEcCtD
Sulfamethoxazole—Fatigue—Lovastatin—atherosclerosis	0.000424	0.00275	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Niacin—atherosclerosis	0.000422	0.00274	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Ezetimibe—atherosclerosis	0.000419	0.00272	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000419	0.00272	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000416	0.0027	CcSEcCtD
Sulfamethoxazole—Asthenia—Rosuvastatin—atherosclerosis	0.000416	0.0027	CcSEcCtD
Sulfamethoxazole—Insomnia—Simvastatin—atherosclerosis	0.000416	0.0027	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Pravastatin—atherosclerosis	0.000416	0.0027	CcSEcCtD
Sulfamethoxazole—Fatigue—Ezetimibe—atherosclerosis	0.000416	0.0027	CcSEcCtD
Sulfamethoxazole—Sulfamethazine—ALB—atherosclerosis	0.000416	0.112	CrCbGaD
Sulfamethoxazole—Dapsone—MPO—atherosclerosis	0.000414	0.112	CrCbGaD
Sulfamethoxazole—Pruritus—Rosuvastatin—atherosclerosis	0.00041	0.00266	CcSEcCtD
Sulfamethoxazole—Skin disorder—Niacin—atherosclerosis	0.00041	0.00266	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Simvastatin—atherosclerosis	0.00041	0.00266	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Pravastatin—atherosclerosis	0.000407	0.00264	CcSEcCtD
Sulfamethoxazole—Sulfamerazine—ALB—atherosclerosis	0.000406	0.11	CrCbGaD
Sulfamethoxazole—Dyspepsia—Simvastatin—atherosclerosis	0.000405	0.00263	CcSEcCtD
Sulfamethoxazole—Anorexia—Niacin—atherosclerosis	0.000402	0.00261	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000402	0.00261	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Simvastatin—atherosclerosis	0.0004	0.00259	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000397	0.00257	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Rosuvastatin—atherosclerosis	0.000397	0.00257	CcSEcCtD
Sulfamethoxazole—Fatigue—Simvastatin—atherosclerosis	0.000396	0.00257	CcSEcCtD
Sulfamethoxazole—Anorexia—Pravastatin—atherosclerosis	0.000396	0.00257	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000394	0.00256	CcSEcCtD
Sulfamethoxazole—Urticaria—Lovastatin—atherosclerosis	0.000391	0.00253	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Lovastatin—atherosclerosis	0.000389	0.00252	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Lovastatin—atherosclerosis	0.000389	0.00252	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000385	0.00249	CcSEcCtD
Sulfamethoxazole—Dizziness—Rosuvastatin—atherosclerosis	0.000384	0.00249	CcSEcCtD
Sulfamethoxazole—Urticaria—Ezetimibe—atherosclerosis	0.000383	0.00248	CcSEcCtD
Sulfamethoxazole—Insomnia—Niacin—atherosclerosis	0.000382	0.00248	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Ezetimibe—atherosclerosis	0.000381	0.00247	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Ezetimibe—atherosclerosis	0.000381	0.00247	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000379	0.00246	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Niacin—atherosclerosis	0.000376	0.00244	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000376	0.00244	CcSEcCtD
Sulfamethoxazole—Insomnia—Pravastatin—atherosclerosis	0.000376	0.00244	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Niacin—atherosclerosis	0.000372	0.00241	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Pravastatin—atherosclerosis	0.000371	0.0024	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Niacin—atherosclerosis	0.000367	0.00238	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Pravastatin—atherosclerosis	0.000366	0.00237	CcSEcCtD
Sulfamethoxazole—Rash—Rosuvastatin—atherosclerosis	0.000366	0.00237	CcSEcCtD
Sulfamethoxazole—Dermatitis—Rosuvastatin—atherosclerosis	0.000365	0.00237	CcSEcCtD
Sulfamethoxazole—Urticaria—Simvastatin—atherosclerosis	0.000365	0.00237	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Niacin—atherosclerosis	0.000365	0.00236	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Simvastatin—atherosclerosis	0.000364	0.00236	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Simvastatin—atherosclerosis	0.000364	0.00236	CcSEcCtD
Sulfamethoxazole—Headache—Rosuvastatin—atherosclerosis	0.000363	0.00236	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Lovastatin—atherosclerosis	0.000362	0.00235	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Pravastatin—atherosclerosis	0.000361	0.00234	CcSEcCtD
Sulfamethoxazole—Fatigue—Pravastatin—atherosclerosis	0.000358	0.00232	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.000355	0.0023	CcSEcCtD
Sulfamethoxazole—Asthenia—Lovastatin—atherosclerosis	0.000353	0.00229	CcSEcCtD
Sulfamethoxazole—Pruritus—Lovastatin—atherosclerosis	0.000348	0.00226	CcSEcCtD
Sulfamethoxazole—Asthenia—Ezetimibe—atherosclerosis	0.000346	0.00224	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Niacin—atherosclerosis	0.000345	0.00224	CcSEcCtD
Sulfamethoxazole—Nausea—Rosuvastatin—atherosclerosis	0.000345	0.00223	CcSEcCtD
Sulfamethoxazole—Pruritus—Ezetimibe—atherosclerosis	0.000341	0.00221	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00034	0.0022	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Simvastatin—atherosclerosis	0.000339	0.0022	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Lovastatin—atherosclerosis	0.000336	0.00218	CcSEcCtD
Sulfamethoxazole—Urticaria—Niacin—atherosclerosis	0.000335	0.00218	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Niacin—atherosclerosis	0.000334	0.00216	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Niacin—atherosclerosis	0.000334	0.00216	CcSEcCtD
Sulfamethoxazole—Urticaria—Pravastatin—atherosclerosis	0.00033	0.00214	CcSEcCtD
Sulfamethoxazole—Asthenia—Simvastatin—atherosclerosis	0.00033	0.00214	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Ezetimibe—atherosclerosis	0.00033	0.00214	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Pravastatin—atherosclerosis	0.000329	0.00213	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Pravastatin—atherosclerosis	0.000329	0.00213	CcSEcCtD
Sulfamethoxazole—Pruritus—Simvastatin—atherosclerosis	0.000325	0.00211	CcSEcCtD
Sulfamethoxazole—Dizziness—Lovastatin—atherosclerosis	0.000325	0.00211	CcSEcCtD
Sulfamethoxazole—Dizziness—Ezetimibe—atherosclerosis	0.000319	0.00207	CcSEcCtD
Sulfamethoxazole—Sulfamethizole—ALB—atherosclerosis	0.000315	0.0851	CrCbGaD
Sulfamethoxazole—Diarrhoea—Simvastatin—atherosclerosis	0.000315	0.00204	CcSEcCtD
Sulfamethoxazole—Vomiting—Lovastatin—atherosclerosis	0.000313	0.00203	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Niacin—atherosclerosis	0.000311	0.00202	CcSEcCtD
Sulfamethoxazole—Rash—Lovastatin—atherosclerosis	0.00031	0.00201	CcSEcCtD
Sulfamethoxazole—Dermatitis—Lovastatin—atherosclerosis	0.00031	0.00201	CcSEcCtD
Sulfamethoxazole—Headache—Lovastatin—atherosclerosis	0.000308	0.002	CcSEcCtD
Sulfamethoxazole—Vomiting—Ezetimibe—atherosclerosis	0.000307	0.00199	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Pravastatin—atherosclerosis	0.000306	0.00199	CcSEcCtD
Sulfamethoxazole—Dizziness—Simvastatin—atherosclerosis	0.000304	0.00197	CcSEcCtD
Sulfamethoxazole—Rash—Ezetimibe—atherosclerosis	0.000304	0.00197	CcSEcCtD
Sulfamethoxazole—Dermatitis—Ezetimibe—atherosclerosis	0.000304	0.00197	CcSEcCtD
Sulfamethoxazole—Asthenia—Niacin—atherosclerosis	0.000303	0.00196	CcSEcCtD
Sulfamethoxazole—Headache—Ezetimibe—atherosclerosis	0.000302	0.00196	CcSEcCtD
Sulfamethoxazole—Pruritus—Niacin—atherosclerosis	0.000299	0.00194	CcSEcCtD
Sulfamethoxazole—Asthenia—Pravastatin—atherosclerosis	0.000298	0.00193	CcSEcCtD
Sulfamethoxazole—Pruritus—Pravastatin—atherosclerosis	0.000294	0.00191	CcSEcCtD
Sulfamethoxazole—Vomiting—Simvastatin—atherosclerosis	0.000292	0.0019	CcSEcCtD
Sulfamethoxazole—Nausea—Lovastatin—atherosclerosis	0.000292	0.00189	CcSEcCtD
Sulfamethoxazole—Rash—Simvastatin—atherosclerosis	0.00029	0.00188	CcSEcCtD
Sulfamethoxazole—Dermatitis—Simvastatin—atherosclerosis	0.00029	0.00188	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Niacin—atherosclerosis	0.000289	0.00187	CcSEcCtD
Sulfamethoxazole—Headache—Simvastatin—atherosclerosis	0.000288	0.00187	CcSEcCtD
Sulfamethoxazole—Nausea—Ezetimibe—atherosclerosis	0.000286	0.00186	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Pravastatin—atherosclerosis	0.000284	0.00184	CcSEcCtD
Sulfamethoxazole—Dizziness—Niacin—atherosclerosis	0.000279	0.00181	CcSEcCtD
Sulfamethoxazole—Dizziness—Pravastatin—atherosclerosis	0.000275	0.00178	CcSEcCtD
Sulfamethoxazole—Nausea—Simvastatin—atherosclerosis	0.000273	0.00177	CcSEcCtD
Sulfamethoxazole—Vomiting—Niacin—atherosclerosis	0.000268	0.00174	CcSEcCtD
Sulfamethoxazole—Rash—Niacin—atherosclerosis	0.000266	0.00173	CcSEcCtD
Sulfamethoxazole—Dermatitis—Niacin—atherosclerosis	0.000266	0.00172	CcSEcCtD
Sulfamethoxazole—Headache—Niacin—atherosclerosis	0.000265	0.00172	CcSEcCtD
Sulfamethoxazole—Vomiting—Pravastatin—atherosclerosis	0.000264	0.00171	CcSEcCtD
Sulfamethoxazole—Rash—Pravastatin—atherosclerosis	0.000262	0.0017	CcSEcCtD
Sulfamethoxazole—Dermatitis—Pravastatin—atherosclerosis	0.000262	0.0017	CcSEcCtD
Sulfamethoxazole—Headache—Pravastatin—atherosclerosis	0.00026	0.00169	CcSEcCtD
Sulfamethoxazole—Nausea—Niacin—atherosclerosis	0.000251	0.00163	CcSEcCtD
Sulfamethoxazole—Nausea—Pravastatin—atherosclerosis	0.000247	0.0016	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—atherosclerosis	0.000155	0.042	CrCbGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	1.85e-05	0.000155	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ALOX15—atherosclerosis	1.85e-05	0.000155	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOA2—atherosclerosis	1.85e-05	0.000155	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PLA2G2A—atherosclerosis	1.85e-05	0.000155	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ALOX5AP—atherosclerosis	1.85e-05	0.000155	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PDGFB—atherosclerosis	1.85e-05	0.000155	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCG5—atherosclerosis	1.84e-05	0.000154	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.84e-05	0.000154	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLTP—atherosclerosis	1.83e-05	0.000154	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MMP1—atherosclerosis	1.83e-05	0.000153	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCG5—atherosclerosis	1.83e-05	0.000153	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.83e-05	0.000153	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—FABP4—atherosclerosis	1.79e-05	0.00015	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LCAT—atherosclerosis	1.79e-05	0.00015	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—HMOX1—atherosclerosis	1.79e-05	0.00015	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LPA—atherosclerosis	1.78e-05	0.000149	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LPA—atherosclerosis	1.77e-05	0.000148	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOA4—atherosclerosis	1.76e-05	0.000147	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CAV1—atherosclerosis	1.75e-05	0.000147	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	1.75e-05	0.000147	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—APOA1—atherosclerosis	1.75e-05	0.000146	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.73e-05	0.000145	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BGN—atherosclerosis	1.72e-05	0.000144	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.72e-05	0.000144	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOB—atherosclerosis	1.71e-05	0.000143	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BGN—atherosclerosis	1.71e-05	0.000143	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.71e-05	0.000143	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOA5—atherosclerosis	1.7e-05	0.000143	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	1.7e-05	0.000142	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ABCA1—atherosclerosis	1.7e-05	0.000142	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.7e-05	0.000142	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOA5—atherosclerosis	1.69e-05	0.000142	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—F2—atherosclerosis	1.67e-05	0.00014	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTM1—atherosclerosis	1.67e-05	0.000139	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.65e-05	0.000138	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS2—atherosclerosis	1.65e-05	0.000138	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.65e-05	0.000138	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.64e-05	0.000138	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.64e-05	0.000137	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—LPL—atherosclerosis	1.63e-05	0.000137	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PLA2G1B—atherosclerosis	1.63e-05	0.000136	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.62e-05	0.000136	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.61e-05	0.000135	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.61e-05	0.000135	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.6e-05	0.000134	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.6e-05	0.000134	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.6e-05	0.000134	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CG—atherosclerosis	1.6e-05	0.000134	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.6e-05	0.000134	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GPX1—atherosclerosis	1.59e-05	0.000134	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.59e-05	0.000133	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.59e-05	0.000133	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.59e-05	0.000133	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.58e-05	0.000132	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ALOX5—atherosclerosis	1.57e-05	0.000132	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.57e-05	0.000132	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CD36—atherosclerosis	1.55e-05	0.00013	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.53e-05	0.000128	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOA2—atherosclerosis	1.51e-05	0.000127	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.51e-05	0.000127	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.51e-05	0.000127	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.51e-05	0.000127	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.51e-05	0.000127	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.5e-05	0.000125	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.49e-05	0.000125	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—MTHFR—atherosclerosis	1.47e-05	0.000123	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.46e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IGF1—atherosclerosis	1.46e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—HMOX1—atherosclerosis	1.46e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.45e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LPA—atherosclerosis	1.44e-05	0.000121	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPARA—atherosclerosis	1.44e-05	0.000121	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.42e-05	0.000119	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NAMPT—atherosclerosis	1.41e-05	0.000118	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.41e-05	0.000118	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LIPC—atherosclerosis	1.41e-05	0.000118	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.4e-05	0.000117	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LIPC—atherosclerosis	1.4e-05	0.000117	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOC3—atherosclerosis	1.4e-05	0.000117	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BGN—atherosclerosis	1.4e-05	0.000117	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AGT—atherosclerosis	1.4e-05	0.000117	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOB—atherosclerosis	1.4e-05	0.000117	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOC3—atherosclerosis	1.39e-05	0.000117	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LDLR—atherosclerosis	1.39e-05	0.000117	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.39e-05	0.000116	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SERPINE1—atherosclerosis	1.39e-05	0.000116	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOA5—atherosclerosis	1.39e-05	0.000116	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LDLR—atherosclerosis	1.39e-05	0.000116	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOE—atherosclerosis	1.37e-05	0.000115	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CETP—atherosclerosis	1.36e-05	0.000114	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CAV1—atherosclerosis	1.36e-05	0.000114	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTM1—atherosclerosis	1.36e-05	0.000114	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—atherosclerosis	1.36e-05	0.000114	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOA1—atherosclerosis	1.35e-05	0.000113	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CETP—atherosclerosis	1.35e-05	0.000113	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.35e-05	0.000113	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.33e-05	0.000112	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—LPL—atherosclerosis	1.33e-05	0.000112	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS3—atherosclerosis	1.33e-05	0.000111	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.32e-05	0.00011	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.31e-05	0.000109	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.3e-05	0.000109	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.3e-05	0.000109	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GPX1—atherosclerosis	1.3e-05	0.000109	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SCARB1—atherosclerosis	1.3e-05	0.000108	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.29e-05	0.000108	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.27e-05	0.000106	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CD36—atherosclerosis	1.27e-05	0.000106	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.26e-05	0.000105	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CG—atherosclerosis	1.24e-05	0.000104	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.23e-05	0.000103	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HMGCR—atherosclerosis	1.22e-05	0.000102	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—MTHFR—atherosclerosis	1.2e-05	0.0001	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPARG—atherosclerosis	1.19e-05	9.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.19e-05	9.96e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—FABP4—atherosclerosis	1.18e-05	9.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LCAT—atherosclerosis	1.18e-05	9.9e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.18e-05	9.9e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARA—atherosclerosis	1.18e-05	9.85e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—INS—atherosclerosis	1.17e-05	9.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA4—atherosclerosis	1.16e-05	9.72e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.16e-05	9.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.15e-05	9.62e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LIPC—atherosclerosis	1.15e-05	9.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOC3—atherosclerosis	1.14e-05	9.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.14e-05	9.54e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AGT—atherosclerosis	1.14e-05	9.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LDLR—atherosclerosis	1.13e-05	9.49e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOE—atherosclerosis	1.12e-05	9.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.11e-05	9.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CETP—atherosclerosis	1.11e-05	9.27e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CAV1—atherosclerosis	1.11e-05	9.27e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOA1—atherosclerosis	1.1e-05	9.24e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.1e-05	9.24e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.1e-05	9.18e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCA1—atherosclerosis	1.09e-05	9.13e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—atherosclerosis	1.07e-05	8.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.06e-05	8.88e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.05e-05	8.82e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.03e-05	8.65e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NOS3—atherosclerosis	1.03e-05	8.59e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CG—atherosclerosis	1.01e-05	8.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HMGCR—atherosclerosis	1e-05	8.39e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.99e-06	8.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.99e-06	8.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA2—atherosclerosis	9.99e-06	8.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.99e-06	8.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.87e-06	8.26e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARG—atherosclerosis	9.73e-06	8.15e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—atherosclerosis	9.55e-06	8e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—INS—atherosclerosis	9.54e-06	7.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LPA—atherosclerosis	9.53e-06	7.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HMOX1—atherosclerosis	9.41e-06	7.88e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—atherosclerosis	9.39e-06	7.86e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HMOX1—atherosclerosis	9.36e-06	7.83e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BGN—atherosclerosis	9.23e-06	7.73e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA5—atherosclerosis	9.14e-06	7.65e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.03e-06	7.56e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK3—atherosclerosis	9.03e-06	7.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOB—atherosclerosis	9.01e-06	7.55e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOB—atherosclerosis	8.96e-06	7.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCA1—atherosclerosis	8.93e-06	7.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.79e-06	7.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—atherosclerosis	8.77e-06	7.34e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—atherosclerosis	8.76e-06	7.34e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—atherosclerosis	8.75e-06	7.32e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—atherosclerosis	8.72e-06	7.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LPL—atherosclerosis	8.61e-06	7.21e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LPL—atherosclerosis	8.56e-06	7.17e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.49e-06	7.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPX1—atherosclerosis	8.4e-06	7.03e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NOS3—atherosclerosis	8.37e-06	7.01e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPX1—atherosclerosis	8.35e-06	6.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CD36—atherosclerosis	8.18e-06	6.85e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CD36—atherosclerosis	8.13e-06	6.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.75e-06	6.49e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MTHFR—atherosclerosis	7.7e-06	6.45e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.66e-06	6.41e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—atherosclerosis	7.65e-06	6.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.62e-06	6.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARA—atherosclerosis	7.6e-06	6.37e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LIPC—atherosclerosis	7.57e-06	6.34e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARA—atherosclerosis	7.56e-06	6.33e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOC3—atherosclerosis	7.52e-06	6.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LDLR—atherosclerosis	7.48e-06	6.26e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AGT—atherosclerosis	7.36e-06	6.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOB—atherosclerosis	7.34e-06	6.14e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AGT—atherosclerosis	7.32e-06	6.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CETP—atherosclerosis	7.3e-06	6.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOE—atherosclerosis	7.21e-06	6.04e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOE—atherosclerosis	7.17e-06	6.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAV1—atherosclerosis	7.15e-06	5.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—atherosclerosis	7.14e-06	5.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOA1—atherosclerosis	7.13e-06	5.97e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAV1—atherosclerosis	7.11e-06	5.95e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOA1—atherosclerosis	7.09e-06	5.94e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LPL—atherosclerosis	7e-06	5.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.99e-06	5.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPX1—atherosclerosis	6.83e-06	5.72e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CD36—atherosclerosis	6.66e-06	5.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.6e-06	5.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.51e-06	5.45e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CG—atherosclerosis	6.47e-06	5.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.31e-06	5.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARG—atherosclerosis	6.28e-06	5.26e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARG—atherosclerosis	6.25e-06	5.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARA—atherosclerosis	6.19e-06	5.18e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—INS—atherosclerosis	6.16e-06	5.16e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—INS—atherosclerosis	6.13e-06	5.13e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—atherosclerosis	6.09e-06	5.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AGT—atherosclerosis	5.99e-06	5.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.89e-06	4.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOE—atherosclerosis	5.87e-06	4.92e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAV1—atherosclerosis	5.82e-06	4.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOA1—atherosclerosis	5.8e-06	4.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—atherosclerosis	5.65e-06	4.73e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NOS3—atherosclerosis	5.4e-06	4.53e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NOS3—atherosclerosis	5.37e-06	4.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.3e-06	4.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARG—atherosclerosis	5.11e-06	4.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.05e-06	4.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—INS—atherosclerosis	5.02e-06	4.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.94e-06	4.14e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—atherosclerosis	4.91e-06	4.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOB—atherosclerosis	4.84e-06	4.05e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—atherosclerosis	4.72e-06	3.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.71e-06	3.94e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LPL—atherosclerosis	4.62e-06	3.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—atherosclerosis	4.6e-06	3.85e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX1—atherosclerosis	4.51e-06	3.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NOS3—atherosclerosis	4.4e-06	3.68e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CD36—atherosclerosis	4.39e-06	3.68e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.16e-06	3.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARA—atherosclerosis	4.08e-06	3.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.02e-06	3.37e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AGT—atherosclerosis	3.95e-06	3.31e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOE—atherosclerosis	3.87e-06	3.24e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—atherosclerosis	3.85e-06	3.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAV1—atherosclerosis	3.84e-06	3.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA1—atherosclerosis	3.83e-06	3.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.49e-06	2.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARG—atherosclerosis	3.37e-06	2.82e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—INS—atherosclerosis	3.31e-06	2.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—atherosclerosis	3.03e-06	2.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NOS3—atherosclerosis	2.9e-06	2.43e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.65e-06	2.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—atherosclerosis	2.48e-06	2.08e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—atherosclerosis	2.47e-06	2.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—atherosclerosis	2.02e-06	1.69e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—atherosclerosis	1.33e-06	1.12e-05	CbGpPWpGaD
